Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | Apr 24, 2024 | 0.76 | -2.67 |
T-Mobile US | TMUS | Apr 24, 2024 | 164.18 | +0.57 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Apr 24, 2024 | 34.12 | -0.32 |
T. Rowe Price Dividend Growth ETF | TDVG | Apr 24, 2024 | 36.97 | 0.00 |
T. Rowe Price Equity Income ETF | TEQI | Apr 24, 2024 | 38.85 | +0.20 |
T. Rowe Price Group | TROW | Apr 24, 2024 | 111.06 | -0.79 |
T. Rowe Price Growth Stock ETF | TGRW | Apr 24, 2024 | 33.06 | -0.61 |
T2 Biosystems | TTOO | Apr 24, 2024 | 2.76 | +1.47 |
Taboola.com | TBLA | Apr 24, 2024 | 4.17 | -0.24 |
Tactile Systems Technology | TCMD | Apr 24, 2024 | 15.04 | +3.23 |
Taitron Components A | TAIT | Apr 24, 2024 | 3.18 | +0.63 |
Taiwan Fund | TWN | Apr 24, 2024 | 37.34 | +0.84 |
Taiwan Index MSCI Ishares | EWT | Apr 24, 2024 | 46.53 | +0.48 |
Taiwan Semiconductor Manufacturing ADR | TSM | Apr 24, 2024 | 132.97 | -0.34 |
Take-Two Interactive Software | TTWO | Apr 24, 2024 | 142.83 | +0.78 |
Takeda Pharmaceutical ADR | TAK | Apr 24, 2024 | 13.23 | -1.12 |
TAL Education Group ADR | TAL | Apr 24, 2024 | 12.26 | +0.57 |
Talis Biomedical | TLIS | Apr 24, 2024 | 9.20 | +2.11 |
Talkspace | TALK | Apr 24, 2024 | 3.07 | -2.23 |
Talos Energy | TALO | Apr 24, 2024 | 13.53 | -1.60 |
Talphera | TLPH | Apr 24, 2024 | 0.97 | 0.00 |
Tandem Diabetes Care | TNDM | Apr 24, 2024 | 35.12 | +0.43 |
Tanger | SKT | Apr 24, 2024 | 28.65 | +0.53 |
Tango Therapeutics | TNGX | Apr 24, 2024 | 7.76 | -0.13 |
Tantech | TANH | Apr 24, 2024 | 0.56 | -1.93 |
Taoping | TAOP | Apr 24, 2024 | 1.06 | -1.85 |
Tapestry | TPR | Apr 24, 2024 | 40.03 | +1.50 |
Targa Resources | TRGP | Apr 24, 2024 | 116.90 | +0.77 |
Target | TGT | Apr 24, 2024 | 165.34 | -0.70 |
Target Global Acquisition I A | TGAA | Apr 24, 2024 | 11.20 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.